Keith L Black Selected Research

minoxidil sulfate ester

8/2008	Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models.
12/2003	Adenosine 5'-triphosphate-sensitive potassium channel-mediated blood-brain tumor barrier permeability increase in a rat brain tumor model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keith L Black Research Topics

Disease

96	Neoplasms (Cancer) 01/2022 - 01/2002
64	Glioma (Gliomas) 11/2020 - 01/2002
44	Brain Neoplasms (Brain Tumor) 10/2021 - 06/2002
31	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 12/2002
19	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 12/2009
10	Breast Neoplasms (Breast Cancer) 04/2015 - 11/2003
8	Cognitive Dysfunction 01/2022 - 03/2014
6	Disease Progression 01/2022 - 01/2011
6	Inflammation (Inflammations) 01/2021 - 07/2014
5	Amyloidosis 01/2021 - 01/2020
5	Amyloid Plaque 08/2017 - 01/2011
4	Gliosis 10/2020 - 12/2009
4	Lung Neoplasms (Lung Cancer) 05/2015 - 01/2007
3	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021 - 01/2020
3	Astrocytoma (Pilocytic Astrocytoma) 04/2020 - 08/2004
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 03/2009
3	Neoplasm Metastasis (Metastasis) 04/2010 - 01/2005
3	Gliosarcoma 09/2008 - 07/2007
2	Oligodendroglioma 04/2020 - 05/2014
2	Neuroinflammatory Diseases 01/2020 - 01/2019
2	Nervous System Diseases (Neurological Disorders) 01/2019 - 10/2010
2	Wounds and Injuries (Trauma) 03/2016 - 02/2010
2	Triple Negative Breast Neoplasms 12/2013 - 01/2012
2	Carcinogenesis 11/2010 - 02/2007

Drug/Important Bio-Agent (IBA)

24	Pharmaceutical PreparationsIBA 01/2022 - 06/2002
24	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2003
16	VaccinesIBA 01/2022 - 05/2004
14	Amyloid (Amyloid Fibrils)IBA 10/2021 - 12/2009
14	Retinaldehyde (Retinal)IBA 10/2021 - 01/2011
12	Neoplasm Antigens (Tumor Antigens)IBA 09/2014 - 03/2003
11	AntigensIBA 01/2013 - 07/2003
10	poly(malic acid)IBA 01/2019 - 01/2006
10	Antisense OligonucleotidesIBA 06/2014 - 10/2003
8	CytokinesIBA 01/2019 - 01/2002
8	malic acid (malate)IBA 01/2019 - 03/2006
8	NanoconjugatesIBA 01/2019 - 03/2006
7	Temozolomide (Temodar)FDA LinkGeneric 02/2016 - 08/2005
7	laminin 8IBA 10/2007 - 10/2003
6	Glatiramer Acetate (Copaxone)FDA Link 01/2022 - 11/2011
6	Peptides (Polypeptides)IBA 01/2019 - 02/2004
6	Monoclonal AntibodiesIBA 01/2012 - 06/2003
6	MorpholinosIBA 01/2012 - 10/2003
5	PolymersIBA 10/2021 - 01/2008
5	Biological ProductsIBA 01/2018 - 05/2004
5	Laminin (Merosin)IBA 10/2012 - 10/2003
5	Messenger RNA (mRNA)IBA 02/2011 - 01/2003
5	polycefinIBA 04/2008 - 01/2006
4	CurcuminIBA 01/2020 - 09/2015
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2004
4	Transferrin Receptors (Transferrin Receptor)IBA 01/2012 - 01/2006
4	Antineoplastic Agents (Antineoplastics)IBA 01/2011 - 06/2003
4	PotassiumIBA 09/2008 - 06/2002
4	CalciumIBA 09/2008 - 06/2002
4	NS 1619IBA 08/2008 - 06/2002
4	BradykininIBA 03/2007 - 06/2002
3	Immunoconjugates (Immunoconjugate)IBA 11/2020 - 01/2019
3	GadoliniumIBA 01/2020 - 01/2013
3	Contrast MediaIBA 01/2020 - 05/2015
3	AntibodiesIBA 01/2019 - 10/2007
3	Biopolymers (Biopolymer)IBA 01/2019 - 03/2006
3	ErbB Receptors (EGF Receptor)IBA 12/2016 - 10/2012
3	Green Fluorescent ProteinsIBA 08/2015 - 06/2003
3	Cancer VaccinesIBA 09/2014 - 02/2004
3	EnzymesIBA 09/2014 - 09/2008
3	ProdrugsIBA 04/2013 - 11/2010
3	Membrane Proteins (Integral Membrane Proteins)IBA 02/2012 - 11/2002
3	DNA (Deoxyribonucleic Acid)IBA 05/2009 - 04/2004
3	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 03/2007 - 06/2002
3	InterleukinsIBA 09/2006 - 10/2002
3	laminin 9IBA 01/2006 - 08/2004
3	Protein Isoforms (Isoforms)IBA 01/2006 - 08/2004
3	Carboplatin (JM8)FDA LinkGeneric 08/2005 - 06/2003
2	epidermal growth factor receptor VIIIIBA 10/2021 - 12/2016
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2021 - 01/2020
2	Amyloid beta-PeptidesIBA 01/2020 - 12/2009
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020 - 03/2014
2	Particulate MatterIBA 01/2018 - 11/2013
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2007
2	Therapeutic UsesIBA 08/2015 - 09/2009
2	CamptothecinIBA 04/2013 - 09/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012 - 09/2008
2	Nucleosomes (Nucleosome)IBA 01/2012 - 10/2007
2	Complementary DNA (cDNA)IBA 11/2011 - 12/2002
2	Trastuzumab (Herceptin)FDA Link 02/2011 - 04/2010
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2011 - 09/2008
2	EstersIBA 10/2010 - 01/2010
2	Vardenafil Dihydrochloride (Levitra)FDA Link 04/2010 - 09/2008
2	Phosphodiesterase 5 InhibitorsIBA 04/2010 - 09/2008
2	NucleotidesIBA 05/2009 - 01/2007
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2008 - 10/2004

Therapy/Procedure

36	Therapeutics 01/2022 - 03/2002
17	Drug Therapy (Chemotherapy) 01/2020 - 11/2003
15	Immunotherapy 10/2020 - 03/2003
6	Lasers (Laser) 01/2020 - 07/2004
5	Radiotherapy 01/2017 - 05/2004
4	Adjuvant Radiotherapy 06/2016 - 07/2005
3	Oral Administration 04/2010 - 06/2008
2	Immunomodulation 10/2020 - 12/2009
2	Intravenous Injections 01/2020 - 10/2007
2	Craniotomy 03/2016 - 08/2012